TD Waterhouse Canada’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30
Closed -$4.92K 2384
2025
Q4
$4.92K Buy
+30
New +$4.7K ﹤0.01% 1693
2025
Q3
Sell
-250
Closed -$31.6K 2137
2025
Q2
$31.6K Hold
250
﹤0.01% 1218
2025
Q1
$32.1K Hold
250
﹤0.01% 1173
2024
Q4
$36K Hold
250
﹤0.01% 1157
2024
Q3
$36.4K Hold
250
﹤0.01% 1111
2024
Q2
$30.8K Hold
250
﹤0.01% 1135
2024
Q1
$44.5K Hold
250
﹤0.01% 1077
2023
Q4
$42.9K Hold
250
﹤0.01% 977
2023
Q3
$38.7K Hold
250
﹤0.01% 974
2023
Q2
$35.3K Hold
250
﹤0.01% 1011
2023
Q1
$40.8K Sell
250
-125
-33% -$22.3K ﹤0.01% 950
2022
Q4
$60.8K Hold
375
﹤0.01% 864
2022
Q3
$74.1K Hold
375
﹤0.01% 827
2022
Q2
$62.4K Hold
375
﹤0.01% 890
2022
Q1
$70.5K Hold
375
﹤0.01% 927
2021
Q4
$85.9K Buy
+375
New +$101K ﹤0.01% 908

Other funds holding RGEN

TD Waterhouse Canada's RGEN Position: Q1 2026 in Review

TD Waterhouse Canada sold out of Repligen (RGEN) in Q1 2026, closing a stake of 30 shares — an estimated $4.92K sold.

TD Waterhouse Canada first reported a position in RGEN in Q4 2021 and held it in 16 quarters. The position peaked at $85.9K in Q4 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • TD Waterhouse Canada reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 30 Repligen shares in Q1 2026, an estimated $4.92K.
  • TD Waterhouse Canada first reported a position in Repligen in Q4 2021 and held it in 16 quarters.
  • TD Waterhouse Canada's Repligen position peaked at $85.9K in Q4 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.